VectivBio Holding AG - Ordinary Shares (NQ:VECT)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 7, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about VectivBio Holding AG - Ordinary Shares

< Previous 1 2 3 Next >

Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares

June 29, 2023

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals

June 26, 2023

From VectivBio AG

Via GlobeNewswire

Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio

June 16, 2023

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

What 4 Analyst Ratings Have To Say About VectivBio Holding ↗

May 23, 2023

Via Benzinga

Piper Sandler Maintains Overweight Rating for VectivBio Holding: Here's What You Need To Know ↗

April 20, 2023

Via Benzinga

Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround ↗

June 12, 2023

Ironwood's plan to purchase a smaller biotech should address some issues that have shareholders concerned.

Via The Motley Fool

VECTIVBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of VectivBio Holding AG - VECT

June 06, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree ↗

June 02, 2023

Big Pharma is facing a patent cliff that could siphon off billions in revenue.

Via Investor's Business Daily

VECTIVBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of VectivBio Holding AG - VECT

May 25, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023 ↗

May 23, 2023

Via Benzinga

Why Ironwood Pharmaceuticals Stock Bumped Higher Today ↗

May 22, 2023

Investors indicated approval of the company's upcoming $1 billion asset purchase.

Via The Motley Fool

Ironwood Scoops Up Gastrointestinal Diseases Player For $1B ↗

May 22, 2023

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) has agreed to acquire VectivBio Holding AG (NASDAQ: VECT) for $17.00 per share in an all-cash transaction with an estimated aggregate consideration of...

Via Benzinga

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 22, 2023

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.

Via Benzinga

Why Shares of VectivBio Holding Are Up Today ↗

May 22, 2023

A buyout offer by Ironwood Pharmaceuticals lifted the clinical-stage biotech's stock.

Via The Motley Fool

Merger Monday ↗

May 22, 2023

This morning, Chevron announced a deal to acquire PDC Energy for $72 per share in stock.

Via Talk Markets

Why VectivBio Shares Are Surging Monday ↗

May 22, 2023

VectivBio Holding AG (NASDAQ: VECT) shares are trading higher Monday after GI-focused healthcare company Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) agreed to

Via Benzinga

US Stocks Mixed; Nordic American Tankers Posts Upbeat Results ↗

May 22, 2023

U.S. stocks traded mixed this morning, with the Dow Jones trading slightly lower on Monday. Following the market opening Monday, the Dow traded down 0.01% to 33,422.94 while the NASDAQ rose 0.09% to...

Via Benzinga

VectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 Billion ↗

May 22, 2023

Both companies are working on treatments for gastrointestinal diseases.

Via Investor's Business Daily

Benzinga Pro's Top 5 Stocks To Watch For Monday, May 22, 2023: MU, RKT, DLTR, LDOS, IRWD ↗

May 22, 2023

Micron Technology (MU) - Shares were down about 4% Monday morning following a report the Chinese government found cybersecurity issues related to Micron's products. Chinese officials have asked

Via Benzinga

VECT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of VectivBio Holding AG Is Fair to Shareholders

May 22, 2023

From Halper Sadeh LLC

Via Business Wire

VectivBio Publishes Invitation to the Annual General Meeting

May 10, 2023

From VectivBio AG

Via GlobeNewswire

VectivBio Reports Full Year 2022 Financial Results and Provides Business Update

April 19, 2023

From VectivBio AG

Via GlobeNewswire

VectivBio to Report Full Year 2022 Financial Results and Provide Business Update on Wednesday, April 19, 2023

April 12, 2023

Management to Host Conference Call Wednesday, April 19, 2023, at 8.00 a.m. ET

From VectivBio AG

Via GlobeNewswire

VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan

March 13, 2023

Single-dose study to assess pharmacokinetics, pharmacological activity, safety and tolerability in healthy Japanese men and women

From VectivBio AG

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022 ↗

December 13, 2022

Via Benzinga

VectivBio Announces Results of Extraordinary General Meeting

December 09, 2022

-Wouter Joustra Elected to the Board of Directors

From VectivBio AG

Via GlobeNewswire

VectivBio Publishes Invitation to the Extraordinary General Meeting of Shareholders

November 16, 2022

From VectivBio AG

Via GlobeNewswire

VectivBio to Present at the 2022 Jefferies London Healthcare Conference

November 09, 2022

From VectivBio AG

Via GlobeNewswire

VectivBio Announces Completion of Enrollment for Colon-In-Continuity (CIC) Cohort of STARS Pivotal Phase 3 Study Investigating Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF)

November 03, 2022

From VectivBio AG

Via GlobeNewswire

VectivBio Announces Closing of $125 Million Underwritten Offering of Ordinary Shares

October 18, 2022

From VectivBio AG

Via GlobeNewswire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.